| Literature DB >> 28039591 |
Sheng Tu1, Fudong Hu2, Wei Cai1, Liyan Xiao3, Linlin Zhang1, Hong Zheng1, Qiong Jiang1, Lianglong Chen4.
Abstract
There are no previous studies showing how to visualize polymeric bioresorbable scaffolds (BRSs) by micro-computed tomography (mCT). There are no previous studies showing how to visualize polymeric bioresorbable scaffolds (BRSs) by micro-computed tomography (mCT). This study aimed to explore the feasibility of detecting polymeric BRS with 3-dimensional reconstruction of BRS images by contrast-enhanced mCT and to determine the optimal imaging settings. BRSs, made of poly-L-lactic acid (PLLA), were implanted in coronary bifurcation models. Five treatments were conducted to examine an optimal condition for imaging BRSs: Baseline treatment, samples were filled with normal saline and scanned with mCT immediately; Treatment-1, -2, -3 and -4, samples were filled with contrast medium and scanned with mCT immediately and 1, 2 and 3 h thereafter, corresponding to soaking time of contrast medium of 0, 1, 2 and 3 h. Compared to Baseline, mCT scanning completely discriminate the scaffold struts from the vascular lumen immediately after filling the samples with contrast agent but not from the vascular wall until the contrast agent soaking time was more than 2 h (Treatment-3 and -4). By setting 10-15 HU as a cut-point of CT values, the scaffold strut detectable rate at Baseline and Teatment-1, -2, -3 and -4 were 1.23 ± 0.31%, 1.65 ± 0.26%, 58.14 ± 12.84%, 97.97 ± 1.43% and 98.90 ± 0.38%, respectively (Treatment-3 vs. Treatment-2, p < 0.01); meanwhile, the success rate of 3D BRS reconstruction with high quality images at Baseline and Teatment-1, -2, -3 and -4 were 1.23%, 1.65%, 58.14%, 97.97% and 98.90%, respectively (Treatment-3 vs. Treatment-2, p < 0.01). In conclusions, reconstruction of 3D BRS images is technically feasible by contrast-enhanced mCT and soaking time of contrast agent for more than 2 h is necessary for complete separation of scaffold struts from the surrounding structures in the phantom samples.Entities:
Keywords: Bioresorbable scaffolds; Contrast medium; Micro-computed tomography; Three-dimensional reconstruction
Mesh:
Substances:
Year: 2016 PMID: 28039591 PMCID: PMC5383680 DOI: 10.1007/s10554-016-1049-z
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
CT values and detectable struts in different contrast settings
| CT value (HU) | SDR (%) | |||
|---|---|---|---|---|
| Vascular wall | Vascular lumen | Scaffold struts | ||
| Baseline | 3.06 ± 2.37 | 3.06 ± 2.19 | 3.13 ± 1.84 | 1.23 ± 0.31 |
| Treatment-1 | 3.21 ± 2.24 | 231.73 ± 22.19*,▲ | 3.12 ± 2.35 | 1.65 ± 0.26 |
| Treatment-2 | 107.91 ± 16.27* | 228.72 ± 25.92*,▲ | 3.21 ± 2.39∇,Δ | 58.14 ± 12.84* |
| Treatment-3 | 171.29 ± 16.97*# | 232.15 ± 24.15*,▲ | 3.13 ± 2.46∇,Δ | 97.97 ± 1.43*,# |
| Treatment-4 | 178.21 ± 16.62*# | 233.92 ± 21.64*,▲ | 3.12 ± 2.41∇,Δ | 98.90 ± 0.38*,# |
Comparison of CT values among treatments: Treatment-1, -2, -3 and -4 vs. Baseline, *p < 0.01, respectively; Treatment-3 and -4 vs. Treatment-2, # p < 0.01, respectively
Comparison of CT values among 3-components of the phantom sample: versus vascular wall, ∇ p < 001; versus vascular lumen, Δ p < 001; versus vascular wall, ▲ p < 001
SDR scaffold detectable rate
Fig. 1MCT raw data and reconstructed 3D images of BRS in different settings. The cross-sectional images (raw data) of a phantom sample acquired by mCT scanning and corresponding 3D reconstructed images of BRS in different treatments. At Baseline, mCT scanning was unable to distinguish the three components of the phantom sample with only gold markers being detected. Regardless of complete separation of the scaffold struts from the vascular lumen immediately after filling the lumen with contrast agent, mCT scanning could not clearly separate the struts from the vascular wall, failing to reconstruct a 3D BRS image in Treatment-1; and could only separate partial struts from the vascular wall, resulting in a suboptimal 3D BRS image with some contamination of the vascular wall signal in Treatment-2. Till to Treatment-3, mCT scanning was able to clearly separate the struts from the vascular wall, enabling to completely reconstruct 3D BRS images with high quality in Treatment-3 and -4
Quality of 3D reconstructed images in different contrast settings
| Image quality | |||
|---|---|---|---|
| Success (%) | Partial success (%) | Failure (%) | |
| Baseline | 1.23 | 0 | 98.77 |
| Treatment-1 | 1.65 | 0 | 98.35 |
| Treatment-2 | 0 | 58.14 | 41.86 |
| Treatment-3 | 97.97* | 2.03* | 0* |
| Treatment-4 | 98.90*,# | 1.10*,# | 0*,# |
Comparison of image quality among different contrast settings: Vs. Baseline, Treatment-1 and -2, *p < 0.01, respectively; vs. Treatment-3, # p > 0.05
Fig. 2Display and application of 3D BRS images in bench testing. After acquisition of high quality raw data of BRSs by using contrast-enhanced mCT, 3D BRS images could be easily reconstructed and displaying in various formats: full 3D images (1st row A, F, K), transverse cutting images viewed distally to proximally, or vice versa, for inspection of MB ostium (2nd row B, G, L) and SB ostium (3rd row C, H, M), coronal cutting images for examination of bifurcated scaffold morphological features (e.g., scaffold expansion, coverage, overlapping, distortion, rupture and so on) (4th row D, I, N), and strut cross-sectional images (so called strut footprints) for accurately measuring key parameters of bifurcated scaffold morphology (e.g., scaffold luminal diameter and area, luminal symmetry, neocarina length and so on) (5th row E, J, O). Also, in this case, BRSs (LePu Medical, Beijing, China) was used to ex vivo emulate the three bifurcation stenting techniques: CULOTTE (upper panels A, B, C, D, E), TAP (middle panels F, G, H, I, J) and CRUSH (lower panels K, L, M, N, O) with clearly showing the morphological characteristics of different bifurcated stenting techniques by 3D reconstructed BRS images